Insights

Regulatory risk Diopsys recently resolved False Claims Act and related state violations with a settlement up to 14.25 million, signaling heightened regulatory scrutiny in vision testing services. This creates a sales opportunity to offer compliant documentation workflows, quality assurance tools, and training packages to healthcare providers and distributors.

ARGOS platform Multiple launches and updates of the ARGOS system since 2020 indicate ongoing product expansion in ERG and VEP testing. This presents a chance to upsell advanced diagnostics modules, integration services with clinics and hospitals, and bundled service agreements around ARGOS deployments.

Strategic partnerships Past mergers and collaborations with Lumithera suggest a channel for co-selling or integration opportunities within ophthalmology treatment ecosystems. Explore joint go-to-market programs, co-branded solutions, and referral partnerships with complementary devices and therapies.

Moderate growth profile Current revenue range and small to mid-size employee base indicate a niche但 expansive market potential. Focus on scalable, outcome-driven sales bundles, including remote monitoring, maintenance, and training for clinics expanding visual health services.

Global readiness Established online presence and diverse tech stack imply readiness for ecommerce and digital marketing partnerships. Propose solutions for harmonizing sales channels, secure data handling, and customer education portals to accelerate adoption across clinics and distributors.

Similar companies to Diopsys

Diopsys Tech Stack

Diopsys uses 8 technology products and services including Crazy Egg, WordPress, CookieYes, and more. Explore Diopsys's tech stack below.

Media & News

Diopsys's Email Address Formats

Diopsys uses at least 3 email formats:
Diopsys Email FormatsExamplePercentage
FLast@diopsys.comJDoe@diopsys.com
95%
Last@diopsys.comDoe@diopsys.com
3%
FMiddleLast@diopsys.comJMichaelDoe@diopsys.com
2%

Frequently Asked Questions

What is Diopsys's phone number?

Minus sign iconPlus sign icon
You can contact Diopsys's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Diopsys's official website and social media links?

Minus sign iconPlus sign icon
Diopsys's official website is diopsys.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Diopsys generate?

Minus sign iconPlus sign icon
As of November 2026, Diopsys's annual revenue is estimated to be $1M - $10M.

What is Diopsys's NAICS code?

Minus sign iconPlus sign icon
Diopsys's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Diopsys have currently?

Minus sign iconPlus sign icon
As of November 2026, Diopsys has approximately 29 employees across 3 continents, including North America, Africa and Asia. Key team members include Chief Executive Officer: S. W., Vice President , International Sales: B. H. and Senior Vice President: M. P. Explore Diopsys's employee directory with LeadIQ.

What industry does Diopsys belong to?

Minus sign iconPlus sign icon
Diopsys operates in the Medical Equipment Manufacturing industry.

What technology does Diopsys use?

Minus sign iconPlus sign icon
Diopsys's tech stack includes Crazy Egg, WordPress, CookieYes, Shopify, WooCommerce, WP Engine, Imperva and Piwik.

What is Diopsys's email format?

Minus sign iconPlus sign icon
Diopsys's email format typically follows the pattern of FLast@diopsys.com. Find more Diopsys email formats with LeadIQ.

How much funding has Diopsys raised to date?

Minus sign iconPlus sign icon
As of November 2026, Diopsys has raised $1M in funding. The last funding round occurred on Oct 17, 2019 for $1M.

When was Diopsys founded?

Minus sign iconPlus sign icon
Diopsys was founded in 1998.
Diopsys logo

Diopsys

Medical Equipment ManufacturingPennsylvania, United States11-50 Employees

Diopsys is a medical equipment manufacturer based in Middletown, Pennsylvania, focused on diagnostic systems that evaluate the visual pathway and neuronal responses. Its NOVA Vision Testing System analyzes the entire pathway for visual and neuron-visual disorders, providing clinicians with a tool to assess function across relevant stages of vision, from the retina to cortical processing. The company targets eye care and neuro-ophthalmology settings, helping specialists identify and monitor conditions that affect vision through objective testing of visual and electrophysiological responses. Diopsys operates within the medical device industry, positioning itself as a provider of specialized diagnostic technology within a market that emphasizes comprehensive, functional assessment of vision. The organization has a history of product introductions and collaborations in the field, including the launch of ARGOS, a tabletop ERG and VEP testing platform, and a strategic development that aligns with broader diagnostic monitoring capabilities.

Section iconCompany Overview

Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
1998
Employees
11-50

Section iconFunding & Financials

  • $1M

    Diopsys has raised a total of $1M of funding over 1 rounds. Their latest funding round was raised on Oct 17, 2019 in the amount of $1M as a Venture Round.

  • $1M - $10M

    Diopsys's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.